Author name: Swaraj Paul Barooah

.

IP Leadership Forum 2014

/ By / Event, Sponsored

SpicyIP is pleased to announce the IP Leadership Forum 2014, an international IP conference on the theme “IP Challenges in today’s Turbulent Environment”. The 3 day event will be held from January 7th to January 9th at Le Meridien, New Delhi. If the speaker-page is anything to go by, this is bound to be a terrific event and a great opportunity to meet and interact with several top IP professionals on recent developments in the IP world. WIPO’s PCT Seminar […]

IP Leadership Forum 2014 Read More »

Guest Post: Flowers of the Trademark War

/ By / Trademark

SpicyIP is glad to bring our readers a guest post on trademarks and keyword advertising. Harish Goel and Ashish Goel take us through a recent decision from the High Court of Justice of England and Wales. Although belated (largely due to inadvertent delays on my side – apologies to Harish and Ashish), the decision is useful at examining the interface of trademarks and new online business strategies. Ashish Goel graduated from NUJS in 2012 and Harish Goel is reading business at XLRI-Jamshedpur.

Guest Post: Flowers of the Trademark War Read More »

Framing debates on IP – Part III

/ By / Patent

This is third and final part on “Framing debates on IP & Health”. Part I and Part II can be accessed by clicking on the links above. I want to use this series to argue that the manner in which IP debates are framed in the health context, play a large role in claim-staking, even if the claims used are ones that ought to have no role in IP policy. Further, that this manner of framing is more useful to

Framing debates on IP – Part III Read More »

Framing debates on IP & Health – Part II

/ By / Patent

This is part 2 of a 3 part series on “Framing debates on IP & Health”. As mentioned in part I, I want to use this series to argue that the manner in which IP debates are framed in the health context, play a large role in claim-staking, even if the claims used are ones that ought to have no role in IP policy. Further, that this manner of framing is more useful to the traditional ‘access’ side of the

Framing debates on IP & Health – Part II Read More »

Framing debates on IP & Health – Part I

/ By / Patent

This is the first of a 3 part post. In this series, I want to argue that the manner in which IP debates are framed in the health context, play a large role in claim-staking, even if the claims used are ones that ought to have no role in IP policy. Further, that this manner of framing is more useful to the traditional ‘access’ side of the debate than it is to the ‘innovator’ side – and that despite being more

Framing debates on IP & Health – Part I Read More »

Two MHRD IP Chair Professors axed; Reasons unknown

/ By / Uncategorized

In a shocking development, Livelaw reports that as of last month, Professor N.S.Gopalakrishnan has been removed as Ministry of Human Resource Development (MHRD) Chair Professor at Cochin University of Science and Technology (CUSAT) without any reason being disclosed.  As those in the IP community would know, Prof Gopalakrishnan is one of the foremost authorities and an internationally recognized expert in the field. One would be hard-pressed to convincingly argue that the Chair position would have even existed at CUSAT had

Two MHRD IP Chair Professors axed; Reasons unknown Read More »

SpicyIP Tidbit: IPA continues communication with Pfizer over pharma innovation policy disputes

/ By / Patent

Readers may remember the posts we did on Pfizer’s testimony before the US House of Representatives and the ensuing series of correspondence regarding it. (See here, here and here). While that was part of the larger issue of US putting pressure on India to change its pharma patent policies, it has been useful in that the exchange of communication has resulted in an actual articulation of reasons behind allegations, rather than mere unilateral claims and allegations (eg: The Special 301

SpicyIP Tidbit: IPA continues communication with Pfizer over pharma innovation policy disputes Read More »

Ghost Post: Samsung v. Apple Presidential Enforcement Veto

/ By / Patent

SpicyIP subscribers recently received a short blurb from Shamnad on this FT article regarding the hypocrisy of stamping ‘national interest’ considerations as valid only when certain countries declare it. Aside from the hypocrisy of declaring ‘national interest’ valid only when certain nations declare it – let’s not forget that India’s ‘national interest’, declared problematic by the US, is for providing its patients with access to life saving medicines – while US’ ‘national interest’, that is presumably valid, is for ensuring

Ghost Post: Samsung v. Apple Presidential Enforcement Veto Read More »

India 66th on Global Innovation Index 2013

/ By / Innovation

The Global Innovation Index, released today, saw India ranked 66th this year – 2 ranks lower than their 2012 rank and 4 lower than its 2011 rank. The index, available here, is prepared by WIPO, Cornell and INSEAD with Knowledge Partners, Booz & Company, the Confederation of Indian Industry (CII), du and Huawei. As per their Press Release: “Despite the economic crisis, innovation is alive and well. Research and development spending levels are surpassing 2008 levels in most countries and

India 66th on Global Innovation Index 2013 Read More »

Part II: Pfizer’s testimony leads the way as US pressure on India increases

/ By / Patent

Part I of this looked into some of the claims that Pfizer has made. This part looks into what that testimony has led to. 170 Members of US Congress write to Obama criticizing India’s IP regime The effects of Waldron’s testimony, no doubt combined with other lobbying efforts, have led to 170 US Members of Congress writing to President Obama, urging him to ensure ‘these issues are raised at the highest levels of the Indian Government and that they are

Part II: Pfizer’s testimony leads the way as US pressure on India increases Read More »

Scroll to Top